PRESS RELEASE published on 09/02/2025 at 22:15, 1 year 2 months ago Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Nanobiotix to participate in H.C. Wainwright 27th Annual Global Investment Conference with a fireside chat featuring company management. Nanoparticle-based treatments for cancer and major diseases Fireside Chat NANOBIOTIX H.C. Wainwright Conference Late-stage Biotechnology Nanoparticle-based Treatments
BRIEF published on 08/27/2025 at 08:05, 1 year 2 months ago Nanobiotix Announces Voting Rights and Shares Capital Update Euronext Paris Voting Rights Biotechnology Shares Capital NANOBIOTIX
PRESS RELEASE published on 08/27/2025 at 08:00, 1 year 2 months ago Voting Rights and Shares Capital of the Company Nanobiotix announces voting rights and shares capital details as per French Commercial Code regulations. The late-stage clinical biotech company focuses on disruptive therapies in oncology, bioavailability, and CNS disorders Voting Rights French Commercial Code Biotechnology Shares Capital NANOBIOTIX
BRIEF published on 08/11/2025 at 11:34, 1 year 3 months ago Threshold Crossings by The Goldman Sachs Group, Inc. at Nanobiotix Actions Financial Market Goldman Sachs Crossing Thresholds NANOBIOTIX
BRIEF published on 07/07/2025 at 22:20, 1 year 4 months ago NANOBIOTIX: Reclassification and New Patent for JNJ-1900 (NBTXR3) Patent NANOBIOTIX Regulatory JNJ-1900 Harmonization
PRESS RELEASE published on 07/07/2025 at 22:15, 1 year 4 months ago NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3) Nanobiotix announces regulatory harmonization and new composition of matter patent filed for JNJ-1900 (NBTXR3), aiming to reinforce global positioning of potential first-in-class radioenhancer NANOBIOTIX JNJ-1900 Global Positioning Regulatory Harmonization Composition Of Matter Patent
BRIEF published on 06/24/2025 at 12:39, 1 year 4 months ago Goldman Sachs Crosses Stake Threshold in Nanobiotix Stock Market Acquisition Of Shares Goldman Sachs Threshold Crossing NANOBIOTIX
BRIEF published on 06/10/2025 at 22:20, 1 year 5 months ago Number of Shares and Voting Rights of Nanobiotix Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
PRESS RELEASE published on 06/10/2025 at 22:15, 1 year 5 months ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital. The company is a biotechnology pioneer with disruptive therapeutic approaches. Visit www.nanobiotix.com for more info Voting Rights Biotechnology Shares Capital NANOBIOTIX Therapeutic Approaches
BRIEF published on 05/21/2025 at 22:20, 1 year 6 months ago Nanobiotix Reports Q1 2025 Achievements and Financial Status Biotechnology Financial Update NANOBIOTIX JNJ-1900 Cancer Trials
Published on 11/20/2026 at 15:00, 1 day 16 hours ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 1 day 16 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 1 day 17 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 1 day 17 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 1 day 17 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 1 day 7 hours ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 21:36, 1 day 9 hours ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 19:26, 1 day 11 hours ago EQS-Adhoc: TAKKT AG: TAKKT revises its 2026 full-year forecast following the cyberattack
Published on 11/20/2026 at 19:03, 1 day 12 hours ago EQS-Adhoc: Allgeier SE confirms rumors regarding sale process for the Evora Group
Published on 11/20/2026 at 18:34, 1 day 12 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 1 day 13 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 2 days 12 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 08:30, 2 days 22 hours ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing